questionsmedicales.fr
Sciences sociales
Anthropologie
Anthropologie culturelle
Rites funéraires
Rites funéraires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
2
Rites funéraires
Cérémonies
Symptômes
2
Émotions
Rites funéraires
Prévention
2
Planification
Rites funéraires
Documents légaux
Rites funéraires
Traitements
2
Soutien psychologique
Rites funéraires
Complications
2
Conflits familiaux
Rites funéraires
Soutien émotionnel
Rites funéraires
Facteurs de risque
2
Contexte social
Rites funéraires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Rites funéraires : Questions médicales les plus fréquentes",
"headline": "Rites funéraires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Rites funéraires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-27",
"dateModified": "2025-03-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Rites funéraires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Anthropologie culturelle",
"url": "https://questionsmedicales.fr/mesh/D000884",
"about": {
"@type": "MedicalCondition",
"name": "Anthropologie culturelle",
"code": {
"@type": "MedicalCode",
"code": "D000884",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.076.201"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Funérailles",
"alternateName": "Burial",
"url": "https://questionsmedicales.fr/mesh/D002048",
"about": {
"@type": "MedicalCondition",
"name": "Funérailles",
"code": {
"@type": "MedicalCode",
"code": "D002048",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.076.201.450.550.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Crémation",
"alternateName": "Cremation",
"url": "https://questionsmedicales.fr/mesh/D055700",
"about": {
"@type": "MedicalCondition",
"name": "Crémation",
"code": {
"@type": "MedicalCode",
"code": "D055700",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.076.201.450.550.175"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Embaumement",
"alternateName": "Embalming",
"url": "https://questionsmedicales.fr/mesh/D004615",
"about": {
"@type": "MedicalCondition",
"name": "Embaumement",
"code": {
"@type": "MedicalCode",
"code": "D004615",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.076.201.450.550.250"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Rites funéraires",
"alternateName": "Funeral Rites",
"code": {
"@type": "MedicalCode",
"code": "D005655",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Megumi Kondo-Arita",
"url": "https://questionsmedicales.fr/author/Megumi%20Kondo-Arita",
"affiliation": {
"@type": "Organization",
"name": "President's Office, Global Center of Osaka Medical and Pharmaceutical University, Takatsuki, Japan."
}
},
{
"@type": "Person",
"name": "Carl B Becker",
"url": "https://questionsmedicales.fr/author/Carl%20B%20Becker",
"affiliation": {
"@type": "Organization",
"name": "Policy Science Unit, School of Medicine, Kyoto University, Kyoto, Japan."
}
},
{
"@type": "Person",
"name": "Livia Sani",
"url": "https://questionsmedicales.fr/author/Livia%20Sani",
"affiliation": {
"@type": "Organization",
"name": "SULISOM UR 3071, Université de Strasbourg, France."
}
},
{
"@type": "Person",
"name": "Marie-Frédérique Bacqué",
"url": "https://questionsmedicales.fr/author/Marie-Fr%C3%A9d%C3%A9rique%20Bacqu%C3%A9",
"affiliation": {
"@type": "Organization",
"name": "SULISOM UR 3071, Université de Strasbourg, France."
}
},
{
"@type": "Person",
"name": "Yozo Taniyama",
"url": "https://questionsmedicales.fr/author/Yozo%20Taniyama",
"affiliation": {
"@type": "Organization",
"name": "Department of Religious Studies, Tohoku University, Sendai 980-8576, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Oxaliplatin (3 months",
"datePublished": "2022-06-30",
"url": "https://questionsmedicales.fr/article/35772045",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1200/JCO.21.02962"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interactions with DNA Models of the Oxaliplatin Analog (",
"datePublished": "2024-07-05",
"url": "https://questionsmedicales.fr/article/39000496",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25137392"
}
},
{
"@type": "ScholarlyArticle",
"name": "Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With",
"datePublished": "2022-06-06",
"url": "https://questionsmedicales.fr/article/35666229",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1200/JCO.22.00839"
}
},
{
"@type": "ScholarlyArticle",
"name": "Unusual stroke-like symptoms with oxaliplatin use.",
"datePublished": "2023-06-15",
"url": "https://questionsmedicales.fr/article/37323007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10781552231181525"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36252550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000527012"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Sciences sociales",
"item": "https://questionsmedicales.fr/mesh/D012942"
},
{
"@type": "ListItem",
"position": 3,
"name": "Anthropologie",
"item": "https://questionsmedicales.fr/mesh/D000883"
},
{
"@type": "ListItem",
"position": 4,
"name": "Anthropologie culturelle",
"item": "https://questionsmedicales.fr/mesh/D000884"
},
{
"@type": "ListItem",
"position": 5,
"name": "Rites funéraires",
"item": "https://questionsmedicales.fr/mesh/D005655"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Rites funéraires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Rites funéraires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Rites funéraires",
"description": "Comment identifier un rite funéraire spécifique ?\nQuels éléments caractérisent un rite funéraire ?",
"url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Oxaliplatin#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Rites funéraires",
"description": "Quels sentiments peuvent émerger lors d'un rite funéraire ?\nComment le deuil se manifeste-t-il pendant un rite ?",
"url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Oxaliplatin#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Rites funéraires",
"description": "Comment préparer un rite funéraire à l'avance ?\nQuels documents sont nécessaires pour un rite funéraire ?",
"url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Oxaliplatin#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Rites funéraires",
"description": "Quels soutiens psychologiques sont offerts lors des rites ?\nComment les rites funéraires aident-ils au processus de deuil ?",
"url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Oxaliplatin#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Rites funéraires",
"description": "Quelles complications peuvent survenir lors d'un rite ?\nComment gérer les émotions intenses lors d'un rite ?",
"url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Oxaliplatin#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Rites funéraires",
"description": "Quels facteurs influencent les rites funéraires ?\nComment le contexte social affecte-t-il les rites ?",
"url": "https://questionsmedicales.fr/mesh/D005655?mesh_terms=Oxaliplatin#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un rite funéraire spécifique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par l'analyse des symboles, des pratiques et des croyances culturelles."
}
},
{
"@type": "Question",
"name": "Quels éléments caractérisent un rite funéraire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les éléments incluent les rituels, les prières, les offrandes et les cérémonies d'enterrement."
}
},
{
"@type": "Question",
"name": "Quels sentiments peuvent émerger lors d'un rite funéraire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les participants peuvent ressentir de la tristesse, de la colère, de la paix ou de la nostalgie."
}
},
{
"@type": "Question",
"name": "Comment le deuil se manifeste-t-il pendant un rite ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le deuil peut se manifester par des pleurs, des cris ou des comportements de commémoration."
}
},
{
"@type": "Question",
"name": "Comment préparer un rite funéraire à l'avance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de discuter des souhaits avec la famille et de rédiger des directives claires."
}
},
{
"@type": "Question",
"name": "Quels documents sont nécessaires pour un rite funéraire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les documents incluent le certificat de décès et les arrangements préalables si existants."
}
},
{
"@type": "Question",
"name": "Quels soutiens psychologiques sont offerts lors des rites ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conseillers ou des thérapeutes peuvent être présents pour aider les endeuillés."
}
},
{
"@type": "Question",
"name": "Comment les rites funéraires aident-ils au processus de deuil ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils offrent un cadre pour exprimer la douleur et favoriser la mémoire du défunt."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir lors d'un rite ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conflits familiaux ou des désaccords sur les rituels peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer les émotions intenses lors d'un rite ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est important d'avoir un soutien émotionnel et de permettre l'expression des sentiments."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent les rites funéraires ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la culture, la religion, et les traditions familiales."
}
},
{
"@type": "Question",
"name": "Comment le contexte social affecte-t-il les rites ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le contexte social peut déterminer la manière dont les rites sont perçus et pratiqués."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
President's Office, Global Center of Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Publications dans "Rites funéraires" :
4 publications dans cette catégorie
Affiliations :
Policy Science Unit, School of Medicine, Kyoto University, Kyoto, Japan.
Publications dans "Rites funéraires" :
3 publications dans cette catégorie
Affiliations :
SULISOM UR 3071, Université de Strasbourg, France.
Publications dans "Rites funéraires" :
3 publications dans cette catégorie
Affiliations :
SULISOM UR 3071, Université de Strasbourg, France.
Publications dans "Rites funéraires" :
3 publications dans cette catégorie
Affiliations :
Department of Religious Studies, Tohoku University, Sendai 980-8576, Japan.
Publications dans "Rites funéraires" :
3 publications dans cette catégorie
Affiliations :
National Museum of Japanese History, Sakura 285-8502, Japan.
Publications dans "Rites funéraires" :
3 publications dans cette catégorie
Affiliations :
Department of Nursing, Tenri Health Care University, Tenri 632-0018, Japan.
Publications dans "Rites funéraires" :
2 publications dans cette catégorie
Affiliations :
Human and Social Sciences, Université du Québec à Chicoutimi(UQAC), Saguenay, Canada.
Publications dans "Rites funéraires" :
2 publications dans cette catégorie
Affiliations :
Registered Nurse, Professor, Faculty of Nursing, University of Alberta, Canada.
Publications dans "Rites funéraires" :
2 publications dans cette catégorie
Affiliations :
Rural Clinical School, Australian National University Medical School, Australia.
Publications dans "Rites funéraires" :
2 publications dans cette catégorie
Affiliations :
Public Health Palliative Care Unit, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.
Publications dans "Rites funéraires" :
2 publications dans cette catégorie
Affiliations :
Public Health Palliative Care Unit, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.
Publications dans "Rites funéraires" :
2 publications dans cette catégorie
Affiliations :
Public Health Palliative Care Unit, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.
The Perron Institute for Neurological and Translational Science, Perth, Australia.
Publications dans "Rites funéraires" :
2 publications dans cette catégorie
Affiliations :
Nursing Department, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU,Sarriena, Leioa, Spain.
BioCruces-Bizkaia Health Research Institute, Barakaldo, Spain.
Publications dans "Rites funéraires" :
2 publications dans cette catégorie
Affiliations :
Equipe de recherché de l'Association Togolaise pour le Bien-Etre Familial (ATBEF).
Publications dans "Rites funéraires" :
2 publications dans cette catégorie
Affiliations :
Biosystems and Environmental Engineering Research Group, Department of Soil Science and Agricultural Engineering, Faculty of Agriculture, University of Zimbabwe, P.O. Box MP167, Mount Pleasant, Harare, Zimbabwe. Electronic address: wgwenzi@agric.uz.ac.zw.
Publications dans "Rites funéraires" :
2 publications dans cette catégorie
Affiliations :
Department of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
Publications dans "Rites funéraires" :
1 publication dans cette catégorie
Affiliations :
Department of Immunobiology, Yale University School of Medicine, New Haven, CT.
Department of Neurology, Yale University School of Medicine, New Haven, CT.
Publications dans "Rites funéraires" :
1 publication dans cette catégorie
Affiliations :
Department of Immunobiology, Yale University School of Medicine, New Haven, CT.
Department of Pharmacology, Yale University School of Medicine, New Haven, CT.
Publications dans "Rites funéraires" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Yale University School of Medicine, New Haven, CT.
Department of Pharmacology, Yale University School of Medicine, New Haven, CT.
Publications dans "Rites funéraires" :
The combination of oxaliplatin and fluoropyrimidine for 6 months is one of the standard options for adjuvant therapy for high-risk stage II and III colorectal cancers (CRCs). The optimal duration of o...
This open-label, randomized, phase III, noninferiority trial randomly assigned patients with high-risk stage II and III CRC to 3 and 6 months of oxaliplatin with 6 months of fluoropyrimidine groups (3...
In total, 1,788 patients were randomly assigned to the 6-month (n = 895) and 3-month (n = 893) arms, and 83.6% in the 6-month arm and 85.7% in the 3-month arm completed the treatment. The neuropathy r...
This study suggests that adding 3 months of oxaliplatin to 6 months of capecitabine could be considered an alternative adjuvant treatment for stage III CRC (ClinicalTrials.gov identifier: NCT01092481)...
It is generally accepted that adjacent guanine residues in DNA are the primary target for platinum antitumor drugs and that differences in the conformations of the Pt-DNA adducts can play a role in th...
To verify whether the intensification of the upfront chemotherapy backbone with a modified schedule of modified fluorouracil, leucovorin, oxaliplatin, and irinotecan (mFOLFOXIRI) increases the activit...
TRIPLETE was a prospective, open-label, phase III trial in which previously untreated patients with unresectable...
From September 2017 to September 2021, 435 patients were enrolled (control group/experimental group: 217/218) in 57 Italian sites. One hundred sixty (73%) patients treated with mFOLFOXIRI plus panitum...
The intensification of the upfront chemotherapy backbone in combination with panitumumab does not provide additional benefit in terms of treatment activity at the price of increased gastrointestinal t...
Oxaliplatin has become the mainstay of treatment for many cancers, but its use can be accompanied by unusual side effects....
We describe herein a 74-year-old patient with pancreatic cancer who developed severe motor weakness affecting lower extremities after starting treatment with oxaliplatin on three separate occasions. O...
Oxaliplatin had to be discontinued due to suboptimal tolerance and a short-lived clinical response. After discontinuation of oxaliplatin, she did not experience any more similar symptoms. A score of 9...
Rare reports of stroke-like events have previously been described with oxaliplatin. While the exact mechanism of these phenomena is not known, alterations in neuronal sodium channels might be involved...
Adjuvant chemotherapy improves the prognosis of patients with colorectal cancer (CRC) following radical resection. However, the safety and efficacy of oxaliplatin-based chemotherapeutic regimens for e...
We examined 138 Japanese patients who received adjuvant CAPOX therapy for high-risk stage II or III CRC between July 2010 and June 2021 at our hospital. Patients were divided according to an age of 70...
Twenty-three patients (17%) were ≥70 years old. Male patients were predominant in the ≥70 years group (p = 0.006). Patients ≥70 years old had more comorbidities (diabetes, p = 0.014; cardiovascular di...
Adjuvant CAPOX therapy was tolerable in elderly Japanese patients. The prognosis of elderly patients with stage III CRC was similar to that of their younger counterparts. Advanced age itself may not b...
DNA double‑strand break repair is critically involved in oxaliplatin resistance in pancreatic ductal adenocarcinoma (PDAC). Hepatocyte nuclear factor 1 homeobox A (HNF1A) has received increased attent...
Oxaliplatin is a common drug used in the management of colorectal malignancies. Rare neurological side effects including amaurosis fugax, urinary retention, stroke, cranial nerve palsy, dysarthria, an...
Oxaliplatin, similar to Cisplatin, exhibits anticancer activity by interacting with DNA and inducing programmed cell death. It is biotransformed through a number of spontaneous and non-enzymatic proce...
Colorectal cancer (CRC), the most common cancer type, causes high morbidity and mortality. Patients who develop drug resistance to oxaliplatin-based regimens have short overall survival. Thus, identif...
A proteomic screen was performed to reveal altered protein kinase phosphorylation in oxaliplatin-resistant (OR) CRC tumour spheroids. The function of CHK2 was characterised using several biochemical t...
We revealed that the level of phospho-CHK2(Thr68) was elevated in OR CRC cells and in ~30% of tumour samples from patients with OR CRC. We demonstrated that oxaliplatin activated several phosphatidyli...
Our findings suggest that CHK2 activity is critical for modulating oxaliplatin response and that CHK2 is a potential therapeutic target for OR CRC....
Resistance to chemotherapy is the deadlock in cancer treatment. In this study, we used wild-type LOVO (LOVO...